DAmour Kevin (CIK 0001870486)

Latest company ownership

ERNA - Ernexa Therapeutics Inc.
Role: Chief Scientific Officer
Shares held
17,573
Last filed at
Jun 29, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 28, 2022 Jun 29, 2022 Ernexa Therapeutics Inc. Chief Scientific Officer Sell 27.5 -6,077 -34.58% ✗ $3.4K